Adalimumab in recalcitrant severe psoriasis associated with atopic dermatitis

Case Reports in Dermatology

Volumn 5, Issue 3, 2013, Pages 332-335

  Yayli, Savas ^a   Irla, Nathalie ^b   Yawalkar, Nikhil ^b  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adalimumab; Atopic dermatitis; Psoriasis

Indexed keywords

ADALIMUMAB; IMMUNOGLOBULIN E; MOMETASONE FUROATE;

ADULT; ALLERGIC RHINOCONJUNCTIVITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; BIRCH; CASE REPORT; CAT; DERMATOPHAGOIDES; GRASS; HUMAN; LOADING DRUG DOSE; MALE; MEDICAL HISTORY; MIDDLE AGED; OINTMENT; PRICK TEST; PRIORITY JOURNAL; PSORIASIS VULGARIS; RHINOCONJUNCTIVITIS; SKIN TEST; TREATMENT DURATION; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; IMMUNOGLOBULIN BLOOD LEVEL; RECALCITRANT PLAQUE PSORIASIS; TREATMENT RESPONSE;

EID: 84893007146     PISSN: None     EISSN: 16626567     Source Type: Journal    
DOI: 10.1159/000356776     Document Type: Article

References (14)

1. Jacobi A, Antoni C, Manger B, et al: Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2005;52:522-526.
2. Cassano N, Loconsole F, Coviello C, et al: Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int J Immunopathol Pharmacol 2006;19:237-240.
3. Rullan P, Murase J: Two cases of chronic atopic dermatitis treated with soluble tumor necrosis factor receptor therapy. J Drugs Dermatol 2009:8:873-876.
4. Davaine AC, Saraux A, Prigent S, et al: Cutaneous events during treatment of chronic inflammatory joint disorders with anti-tumor necrosis factor alpha: A cross-sectional study. J Eur Acad Dermatol Venereol 2008;22:1471-1477.
5. Chan JL, Davis-Reed L, Kimball AB: Counter-regulatory balance: Atopic dermatitis in patients undergoing infliximab infusion therapy. J Drugs Dermatol 2004;3:315-318.
6. Mangge H, Gindl S, Kenzian H, et al: Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy. J Rheumatol 2003;30:2506-2507.
7. Dumont-Berset M, Laffitte E, Gerber C, et al: Eczematous drug eruption after infliximab. Br J Dermatol 2004;151:1272-1273.
8. Henseler T, Christophers E: Disease concomitance in psoriasis. J Am Acad Dermatol 1995;32:982-986.
9. Guttman-Yassky E, Nograles KE, Krueger JG: Contrasting pathogenesis of atopic dermatitis and psoriasis. 1. Clinical and pathologic concepts. J Allergy Clin Immunol 2011;127:1110-1118.
10. Guttman-Yassky E, Nograles KE, Krueger JG: Contrasting pathogenesis of atopic dermatitis and psoriasis. 2. Immune cell subsets and therapeutic concepts. J Allergy Clin Immunol 2011;127:1420-1432.
11. Eyerich S, Onken AT, Weidinger S, et al: Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med 2011;365:231-238.
12. Wilsmann-Theis D, Hagemann T, Jordan J, et al: Facing psoriasis and atopic dermatitis: Are there more similarities or more differences Eur J Dermatol 2008;18:172-180.
13. Cookson WO, Ubhi B, Lawrence R, et al: Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 2001;27:372-373.
14. Grewe M, Walther S, Gyufko K, et al: Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995;105:407-410.